113 related articles for article (PubMed ID: 35554932)
1. Risk of secondary nonhematologic malignancies after allogeneic stem cell transplantation: A nationwide case-control cohort study.
Park SS; Park SH; Han S
Int J Cancer; 2022 Oct; 151(7):1024-1032. PubMed ID: 35554932
[TBL] [Abstract][Full Text] [Related]
2. Increased Incidence of Human Papillomavirus-Related Precancer or Second Malignancy Among Allogeneic Stem Cell Transplantation Patients: A SEER-Medicare Population Study.
Zhao H; Duan Z; Li M; Chiao E; Ahmed S; Shih YT; Hwang JP
Transplant Cell Ther; 2021 Dec; 27(12):1016.e1-1016.e9. PubMed ID: 34474166
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Disease Incidence After Allogeneic Stem Cell Transplantation: A Nationwide Korean Case-Control Study.
Ha J; Park SH; Park SS; Han S
J Clin Endocrinol Metab; 2022 Mar; 107(4):943-952. PubMed ID: 34905058
[TBL] [Abstract][Full Text] [Related]
4. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
[TBL] [Abstract][Full Text] [Related]
5. Risk of Secondary Malignancies in Hematopoietic Stem Cell Transplantation Recipients: A Nationwide Population-Based Study in Taiwan.
Liu HL; Chen YH; Chung CH; Wu GJ; Tsao CH; Sun CA; Chien WC; Hung CT
Balkan Med J; 2023 Mar; 40(2):131-138. PubMed ID: 36804217
[TBL] [Abstract][Full Text] [Related]
6. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
El-Cheikh J; Crocchiolo R; Furst S; Stoppa AM; Ladaique P; Faucher C; Calmels B; Lemarie C; De Colella JM; Granata A; Coso D; Bouabdallah R; Chabannon C; Blaise D
Am J Hematol; 2013 May; 88(5):370-4. PubMed ID: 23460414
[TBL] [Abstract][Full Text] [Related]
8. The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Heydari K; Shamshirian A; Lotfi-Foroushani P; Aref A; Hedayatizadeh-Omran A; Ahmadi M; Janbabei G; Keyhanian S; Zaboli E; Ghasemzadeh SM; Alizadeh-Navaei R
Clin Transl Oncol; 2020 Oct; 22(10):1825-1837. PubMed ID: 32108275
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.
Tichelli A; Beohou E; Labopin M; Socié G; Rovó A; Badoglio M; van Biezen A; Bader P; Duarte RF; Basak G; Salooja N;
JAMA Oncol; 2019 Feb; 5(2):229-235. PubMed ID: 30476975
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
11. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Modi A; Rybicki L; Majhail NS; Mossad SB
Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.
Satwani P; Baldinger L; Freedman J; Jacobson JS; Guerra J; van de Ven C; Morris E; Garvin J; George D; Bradley MB; Bhatia M; Tallamy B; Schwartz J; Jin Z; Cairo MS
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1587-95. PubMed ID: 19896083
[TBL] [Abstract][Full Text] [Related]
13. Second solid cancers after allogeneic hematopoietic stem cell transplantation.
Gallagher G; Forrest DL
Cancer; 2007 Jan; 109(1):84-92. PubMed ID: 17131350
[TBL] [Abstract][Full Text] [Related]
14. Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan.
Ishida Y; Qiu D; Maeda M; Fujimoto J; Kigasawa H; Kobayashi R; Sato M; Okamura J; Yoshinaga S; Rikiishi T; Shichino H; Kiyotani C; Kudo K; Asami K; Hori H; Kawaguchi H; Inada H; Adachi S; Manabe A; Kuroda T
Int J Clin Oncol; 2016 Jun; 21(3):506-16. PubMed ID: 26620038
[TBL] [Abstract][Full Text] [Related]
15. Better outcome of patients undergoing enteral tube feeding after myeloablative conditioning for allogeneic stem cell transplantation.
Seguy D; Duhamel A; Rejeb MB; Gomez E; Buhl ND; Bruno B; Cortot A; Yakoub-Agha I
Transplantation; 2012 Aug; 94(3):287-94. PubMed ID: 22785249
[TBL] [Abstract][Full Text] [Related]
16. Secondary malignancies after bone marrow transplantation in adults.
Lowsky R; Lipton J; Fyles G; Minden M; Meharchand J; Tejpar I; Atkins H; Sutcliffe S; Messner H
J Clin Oncol; 1994 Oct; 12(10):2187-92. PubMed ID: 7931488
[TBL] [Abstract][Full Text] [Related]
17. Second Malignancies after Hematopoietic Stem Cell Transplantation.
Danylesko I; Shimoni A
Curr Treat Options Oncol; 2018 Feb; 19(2):9. PubMed ID: 29423555
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
[TBL] [Abstract][Full Text] [Related]
19. Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study.
Yun SJ; Bae JM; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Chung KY
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):746-753. PubMed ID: 31494979
[TBL] [Abstract][Full Text] [Related]
20. Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study.
Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Shen CC; Ku FC; Chen SC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
Br J Cancer; 2015 Jan; 112(1):177-84. PubMed ID: 25314066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
